ATE424114T1 - Retrovirales genübertragungssystem und entsprechendes verwendungverfahren - Google Patents
Retrovirales genübertragungssystem und entsprechendes verwendungverfahrenInfo
- Publication number
- ATE424114T1 ATE424114T1 AT99969648T AT99969648T ATE424114T1 AT E424114 T1 ATE424114 T1 AT E424114T1 AT 99969648 T AT99969648 T AT 99969648T AT 99969648 T AT99969648 T AT 99969648T AT E424114 T1 ATE424114 T1 AT E424114T1
- Authority
- AT
- Austria
- Prior art keywords
- tissue
- cell
- transfer system
- gene transfer
- sequence
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
- C12N2740/13041—Use of virus, viral particle or viral elements as a vector
- C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
- C12N2740/13041—Use of virus, viral particle or viral elements as a vector
- C12N2740/13045—Special targeting system for viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2810/00—Vectors comprising a targeting moiety
- C12N2810/50—Vectors comprising as targeting moiety peptide derived from defined protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2810/00—Vectors comprising a targeting moiety
- C12N2810/50—Vectors comprising as targeting moiety peptide derived from defined protein
- C12N2810/80—Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2810/00—Vectors comprising a targeting moiety
- C12N2810/50—Vectors comprising as targeting moiety peptide derived from defined protein
- C12N2810/80—Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates
- C12N2810/85—Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates mammalian
- C12N2810/854—Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates mammalian from hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2810/00—Vectors comprising a targeting moiety
- C12N2810/50—Vectors comprising as targeting moiety peptide derived from defined protein
- C12N2810/80—Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates
- C12N2810/85—Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates mammalian
- C12N2810/859—Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates mammalian from immunoglobulins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
- C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/15—Vector systems having a special element relevant for transcription chimeric enhancer/promoter combination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
- C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
- C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/80—Vectors comprising a special translation-regulating system from vertebrates
- C12N2840/85—Vectors comprising a special translation-regulating system from vertebrates mammalian
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Vehicle Body Suspensions (AREA)
- Radiation-Therapy Devices (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10293398P | 1998-10-01 | 1998-10-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE424114T1 true ATE424114T1 (de) | 2009-03-15 |
Family
ID=22292475
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99969648T ATE424114T1 (de) | 1998-10-01 | 1999-10-01 | Retrovirales genübertragungssystem und entsprechendes verwendungverfahren |
Country Status (9)
Country | Link |
---|---|
US (4) | US6410313B1 (de) |
EP (3) | EP2386646B1 (de) |
AT (1) | ATE424114T1 (de) |
AU (1) | AU1441900A (de) |
CA (1) | CA2346931C (de) |
DE (1) | DE69940521D1 (de) |
DK (1) | DK1115290T3 (de) |
ES (1) | ES2323744T3 (de) |
WO (1) | WO2000018240A1 (de) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE424114T1 (de) | 1998-10-01 | 2009-03-15 | Univ Southern California | Retrovirales genübertragungssystem und entsprechendes verwendungverfahren |
US6899871B2 (en) * | 1998-10-01 | 2005-05-31 | University Of Southern California | Gene delivery system and methods of use |
CA2371946A1 (en) * | 1999-04-29 | 2000-11-09 | Aarhus University | Expression of heterologous genes from an ires translational cassette in retroviral vectors |
US6762031B2 (en) | 2000-06-16 | 2004-07-13 | University Of Medicine And Dentistry Of New Jersey | Targeting viral vectors to specific cells |
US7575924B2 (en) | 2000-11-13 | 2009-08-18 | Research Development Foundation | Methods and compositions relating to improved lentiviral vectors and their applications |
CA2456169C (en) | 2001-08-02 | 2012-05-22 | Didier Trono | Methods and compositions relating to improved lentiviral vector production systems |
JP2005504539A (ja) * | 2001-10-02 | 2005-02-17 | インスティテュット クレイトン ド ラ リシェルシュ | 制限発現レンチウイルス性ベクターに関連する方法及び組成物並びにその応用 |
CN100398649C (zh) * | 2002-05-31 | 2008-07-02 | 浙江养生堂天然药物研究所有限公司 | 一种人白血病相关逆转录病毒基因组核酸序列及其应用 |
WO2004050829A2 (en) * | 2002-08-20 | 2004-06-17 | Aeras Global Tuberculosis Vaccine Foundation | Recombinant double-stranded rna phage, and use of the same |
US7927599B2 (en) * | 2003-09-08 | 2011-04-19 | Ethicon, Inc. | Chondrocyte therapeutic delivery system |
US8257963B2 (en) | 2007-06-01 | 2012-09-04 | Depuy Mitek, Inc. | Chondrocyte container and method of use |
US7897384B2 (en) * | 2003-09-08 | 2011-03-01 | Ethicon, Inc. | Chondrocyte therapeutic delivery system |
CN101065492A (zh) * | 2004-11-24 | 2007-10-31 | 纳诺非科特有限公司 | 病毒载体 |
CA2724740C (en) | 2008-06-30 | 2017-02-21 | Tocagen Inc. | Formulations of 5-fluorocytosine and uses thereof |
US8829173B2 (en) | 2008-09-26 | 2014-09-09 | Tocagen Inc. | Recombinant vectors |
WO2010045002A2 (en) * | 2008-09-26 | 2010-04-22 | Tocagen Inc. | Gene therapy vectors and cytosine deaminases |
WO2010045659A1 (en) | 2008-10-17 | 2010-04-22 | American Gene Technologies International Inc. | Safe lentiviral vectors for targeted delivery of multiple therapeutic molecules |
WO2010148203A2 (en) * | 2009-06-17 | 2010-12-23 | Tocagen Inc. | Producer cells for replication competent retroviral vectors |
CA2816570A1 (en) | 2010-10-31 | 2012-05-03 | Tocagen Inc. | Enhanced cancer treatment and monitoring using recombinant vectors |
EP2568289A3 (de) | 2011-09-12 | 2013-04-03 | International AIDS Vaccine Initiative | Immunselektion von rekombinantem vesikulärem Stomatitisvirus mit Expression von HIV-1-Proteinen durch Breitbandneutralisierungs-Antikörper |
EP2586461A1 (de) | 2011-10-27 | 2013-05-01 | Christopher L. Parks | Von einem eingehüllten Virus abgeleitete Virenpartikel |
US9347065B2 (en) | 2012-03-29 | 2016-05-24 | International Aids Vaccine Initiative | Methods to improve vector expression and genetic stability |
CN104884627A (zh) * | 2012-10-25 | 2015-09-02 | 托卡根公司 | 具有小型启动子盒的逆转录病毒载体 |
US9642921B2 (en) | 2012-12-20 | 2017-05-09 | Tocagen Inc. | Cancer combination therapy and recombinant vectors |
WO2014201449A2 (en) | 2013-06-15 | 2014-12-18 | Tocagen Inc. | Immunosuppressive components associated with retroviral replicating vectors |
JP6894236B2 (ja) * | 2014-03-26 | 2021-06-30 | デノボ バイオファーマ エルエルシー | 免疫刺激活性を有するレトロウイルスベクター |
WO2017007994A1 (en) | 2015-07-08 | 2017-01-12 | American Gene Technologies International Inc. | Hiv pre-immunization and immunotherapy |
CA2996797A1 (en) | 2015-09-04 | 2017-03-09 | Tocagen Inc. | Recombinant vectors comprising 2a peptide |
DK3402483T3 (da) | 2016-01-15 | 2024-01-02 | American Gene Tech Int Inc | Fremgangsmåder og sammensætninger til aktivering af gamma-delta-T-celler |
US10137144B2 (en) | 2016-01-15 | 2018-11-27 | American Gene Technologies International Inc. | Methods and compositions for the activation of gamma-delta T-cells |
US10888613B2 (en) | 2016-02-08 | 2021-01-12 | American Gene Technologies International Inc. | Method of producing cells resistant to HIV infection |
EP4036231A1 (de) | 2016-03-09 | 2022-08-03 | American Gene Technologies International Inc. | Kombinationsvektoren und verfahren zur behandlung von krebs |
WO2017213697A1 (en) * | 2016-06-08 | 2017-12-14 | American Gene Technologies International Inc. | Non-integrating viral delivery system and methods related thereto |
WO2018009246A1 (en) | 2016-07-08 | 2018-01-11 | American Gene Technologies International Inc. | Hiv pre-immunization and immunotherapy |
WO2018017882A1 (en) | 2016-07-21 | 2018-01-25 | American Gene Technologies International Inc. | Viral vectors for treating parkinson's disease |
US11820999B2 (en) | 2017-04-03 | 2023-11-21 | American Gene Technologies International Inc. | Compositions and methods for treating phenylketonuria |
Family Cites Families (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4405712A (en) | 1981-07-01 | 1983-09-20 | The United States Of America As Represented By The Department Of Health And Human Services | LTR-Vectors |
US4650764A (en) | 1983-04-12 | 1987-03-17 | Wisconsin Alumni Research Foundation | Helper cell |
US6133029A (en) | 1988-03-21 | 2000-10-17 | Chiron Corporation | Replication defective viral vectors for infecting human cells |
US6241982B1 (en) | 1988-03-21 | 2001-06-05 | Chiron Corporation | Method for treating brain cancer with a conditionally lethal gene |
US5716826A (en) | 1988-03-21 | 1998-02-10 | Chiron Viagene, Inc. | Recombinant retroviruses |
ATE118247T1 (de) * | 1988-09-27 | 1995-02-15 | Dana Farber Cancer Inst Inc | Vektor, der ein replikationskompetentes hiv-i- provirus und ein heterologes gen enthält. |
US5674486A (en) * | 1991-06-25 | 1997-10-07 | San Diego Regional Cancer Center | Cancer immunotherapy with carrier cells |
DK0598029T3 (da) | 1991-08-07 | 2002-05-27 | W French Anderson | Retrovirale vektorer indeholdende interne ribosome indgangssteder |
WO1993010218A1 (en) | 1991-11-14 | 1993-05-27 | The United States Government As Represented By The Secretary Of The Department Of Health And Human Services | Vectors including foreign genes and negative selective markers |
ATE263252T1 (de) * | 1992-11-09 | 2004-04-15 | Us Health | Erzielbare vektorenpartikel |
US5770428A (en) | 1993-02-17 | 1998-06-23 | Wisconsin Alumni Research Foundation | Chimeric retrovial expression vectors and particles containing a simple retroviral long terminal repeat, BLV or HIV coding regions and cis-acting regulatory sequences, and an RNA translational enhancer with internal ribsome entry site |
DE69420033T2 (de) | 1993-04-06 | 1999-12-23 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Bethesda | Gibbon leukemia virus retrovirale vektoren |
FR2716459B1 (fr) | 1994-02-22 | 1996-05-10 | Univ Paris Curie | Système hôte-vecteur utilisable en thérapie génique. |
US5585096A (en) * | 1994-06-23 | 1996-12-17 | Georgetown University | Replication-competent herpes simplex virus mediates destruction of neoplastic cells |
US20030157070A1 (en) | 1994-12-30 | 2003-08-21 | Jolly Douglas J. | High efficiency ex vivo transduction of cells by high titer recombinant retroviral preparations |
US6117681A (en) | 1995-03-29 | 2000-09-12 | Bavarian Nordic Research Inst. A/S | Pseudotyped retroviral particles |
US20030026789A1 (en) | 1995-05-03 | 2003-02-06 | Richard J. Gregory | Gene therapy using replication competent targeted adenoviral vectors |
GB9604354D0 (en) * | 1996-02-29 | 1996-05-01 | Isis Innovation | Targeting adapters |
US6025192A (en) | 1996-09-20 | 2000-02-15 | Cold Spring Harbor Laboratory | Modified retroviral vectors |
US6248721B1 (en) | 1997-04-09 | 2001-06-19 | Lung-Ji Chang | Method of using mouse model for evaluation of HIV vaccines |
US6207455B1 (en) * | 1997-05-01 | 2001-03-27 | Lung-Ji Chang | Lentiviral vectors |
EP1025208A2 (de) | 1997-10-20 | 2000-08-09 | Universita' Degli Studi Di Padova | Verpackungszellinie zur herstellung von pseudotypisiertem mlv |
FR2773561A1 (fr) | 1998-01-15 | 1999-07-16 | Centre Nat Rech Scient | Utilisation d'une sequence riche en proline pour augmenter le caractere fusogenique d'enveloppes de retrovirus |
CA2327444A1 (en) | 1998-04-29 | 1999-11-04 | Oklahoma Medical Research Foundation | Construction of retroviral producer cells from adenoviral and retroviral vectors |
US6291214B1 (en) | 1998-05-11 | 2001-09-18 | Glaxo Wellcome Inc. | System for generating recombinant viruses |
FR2778670B1 (fr) | 1998-05-18 | 2002-12-13 | Rhone Poulenc Rorer Sa | Methodes et compositions pour la production de particules virales |
AU4089899A (en) | 1998-05-20 | 1999-12-06 | University Of Tennessee Research Corporation, The | Stable envelope proteins for retroviral, viral and liposome vectors and use in gene and drug therapy |
US6322969B1 (en) * | 1998-05-27 | 2001-11-27 | The Regents Of The University Of California | Method for preparing permuted, chimeric nucleic acid libraries |
US6264940B1 (en) | 1998-08-05 | 2001-07-24 | The Research Foundation Of State University Of New York | Recombinant poliovirus for the treatment of cancer |
US6899871B2 (en) | 1998-10-01 | 2005-05-31 | University Of Southern California | Gene delivery system and methods of use |
ATE424114T1 (de) | 1998-10-01 | 2009-03-15 | Univ Southern California | Retrovirales genübertragungssystem und entsprechendes verwendungverfahren |
US6576463B1 (en) | 1999-01-15 | 2003-06-10 | The Regents Of The University Of California | Hybrid vectors for gene therapy |
CA2371946A1 (en) | 1999-04-29 | 2000-11-09 | Aarhus University | Expression of heterologous genes from an ires translational cassette in retroviral vectors |
EP1059357A1 (de) | 1999-06-09 | 2000-12-13 | Universite Pierre Et Marie Curie Paris Vi | Replizierende oder 'semi-replizierende' retrovirale Konstrukte, ihre Herstellung und Verwendungen für den Gentransfer |
EP1059356B1 (de) | 1999-06-09 | 2005-11-02 | Universite Pierre Et Marie Curie Paris Vi | Replizierende retrovirale Konstrukte, ihre Herstellung und Verwendungen für den Gentransfer |
WO2001040488A1 (en) | 1999-11-30 | 2001-06-07 | Novartis Ag | Increased transgene expression in retroviral vectors having scaffold attachment region |
US6692736B2 (en) | 2000-03-24 | 2004-02-17 | Cell Genesys, Inc. | Cell-specific adenovirus vectors comprising an internal ribosome entry site |
US20020137889A1 (en) | 2000-09-18 | 2002-09-26 | Soong Nay Wei | Stress resistant retroviruses |
WO2002042482A2 (en) | 2000-11-27 | 2002-05-30 | Chiron Corporation | Functional lentiviral vector from an mlv-based backbone |
WO2002061104A2 (en) | 2001-01-30 | 2002-08-08 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Hybrid adenoviral vector |
DE10111433A1 (de) | 2001-03-09 | 2002-09-19 | Bundesrepublik Deutschland Let | Replikationskompetente molekulare Klone von porcinem endogenem Retrovirus der Klasse A und Klasse B,abgeleitet von Schweine- und humanen Zellen |
WO2002092786A2 (en) | 2001-03-26 | 2002-11-21 | The Board Of Trustees Of The Leland Stanford Junior University | A helper dependent adenoviral vector system and methods for using the same |
US7211247B2 (en) | 2001-04-09 | 2007-05-01 | University Of Southern California | Lentivirus vectors for gene transfer to alveolar epithelial cells |
JP2002335965A (ja) | 2001-05-14 | 2002-11-26 | Japan Science & Technology Corp | 細胞特異的発現複製ベクター |
DE10143237A1 (de) | 2001-09-04 | 2003-03-20 | Icon Genetics Ag | Herstellung künstlicher interner ribosomaler Eingangsstellenelemente (Ires-Elemente) |
FR2832424B1 (fr) | 2001-11-20 | 2004-09-24 | Genethon Iii | Plasmide chimere comprenant un genome retroviral replicatif et utilisations |
JP2005515784A (ja) | 2002-02-01 | 2005-06-02 | トランジェーヌ、ソシエテ、アノニム | Podに関連した細胞活性を調節するためのアデノウイルスベクター |
CA2524892A1 (en) | 2002-05-17 | 2003-11-27 | Retrovec Aps | A purified polypeptide, isolated nucleic acids encoding said polypeptide, vectors and use thereof |
WO2005118802A2 (en) | 2004-06-03 | 2005-12-15 | The Regents Of The University Of California | Targeting pseudotyped retroviral vectors |
US20070003522A1 (en) | 2004-07-08 | 2007-01-04 | Albritton Lorraine M | Methods and compositions for improved retroviral gene and drug delivery |
CN101065492A (zh) | 2004-11-24 | 2007-10-31 | 纳诺非科特有限公司 | 病毒载体 |
WO2007095201A2 (en) | 2006-02-15 | 2007-08-23 | The Regents Of The University Of California | Pseudotyped retroviral vectors and methods of use thereof |
US8557971B2 (en) | 2006-03-17 | 2013-10-15 | Aarhus Universitet | Chimeric viral envelopes |
WO2008151633A2 (en) | 2007-06-15 | 2008-12-18 | Skau Aps | Vectors for vaccines against lentivirus infections |
CA2724740C (en) | 2008-06-30 | 2017-02-21 | Tocagen Inc. | Formulations of 5-fluorocytosine and uses thereof |
WO2010045002A2 (en) | 2008-09-26 | 2010-04-22 | Tocagen Inc. | Gene therapy vectors and cytosine deaminases |
-
1999
- 1999-10-01 AT AT99969648T patent/ATE424114T1/de active
- 1999-10-01 EP EP10183675.7A patent/EP2386646B1/de not_active Expired - Lifetime
- 1999-10-01 AU AU14419/00A patent/AU1441900A/en not_active Abandoned
- 1999-10-01 ES ES99969648T patent/ES2323744T3/es not_active Expired - Lifetime
- 1999-10-01 EP EP99969648A patent/EP1115290B1/de not_active Expired - Lifetime
- 1999-10-01 WO PCT/US1999/023016 patent/WO2000018240A1/en active Application Filing
- 1999-10-01 DE DE69940521T patent/DE69940521D1/de not_active Expired - Lifetime
- 1999-10-01 DK DK99969648T patent/DK1115290T3/da active
- 1999-10-01 EP EP07020687A patent/EP1932426A1/de not_active Withdrawn
- 1999-10-01 CA CA2346931A patent/CA2346931C/en not_active Expired - Lifetime
- 1999-10-01 US US09/409,650 patent/US6410313B1/en not_active Expired - Lifetime
-
2002
- 2002-01-11 US US10/045,178 patent/US8741279B2/en not_active Expired - Fee Related
-
2011
- 2011-11-07 US US13/290,989 patent/US8652460B2/en not_active Expired - Fee Related
-
2014
- 2014-02-14 US US14/181,124 patent/US20140234958A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20020127697A1 (en) | 2002-09-12 |
CA2346931C (en) | 2011-11-29 |
AU1441900A (en) | 2000-04-17 |
US20120052554A1 (en) | 2012-03-01 |
WO2000018240A1 (en) | 2000-04-06 |
US6410313B1 (en) | 2002-06-25 |
US20140234958A1 (en) | 2014-08-21 |
EP1932426A1 (de) | 2008-06-18 |
US8741279B2 (en) | 2014-06-03 |
US8652460B2 (en) | 2014-02-18 |
DK1115290T3 (da) | 2009-06-22 |
ES2323744T3 (es) | 2009-07-23 |
EP1115290A1 (de) | 2001-07-18 |
EP1115290B1 (de) | 2009-03-04 |
CA2346931A1 (en) | 2000-04-06 |
DE69940521D1 (de) | 2009-04-16 |
EP2386646A1 (de) | 2011-11-16 |
EP1115290A4 (de) | 2002-12-04 |
EP2386646B1 (de) | 2016-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE424114T1 (de) | Retrovirales genübertragungssystem und entsprechendes verwendungverfahren | |
DK458480A (da) | Dna, recombinant plasmid og mikroorganisme indeholdende dette samt fremgangsmaader til fremstilling deraf | |
DE59800697D1 (de) | Feuerfester werkstoff auf basis chromkorund, chromkorund-stein sowie verwendung des steins | |
BRPI9912663B1 (pt) | vacina contra cáncer e polipeptìdeo. | |
WO1995032298A3 (en) | Safe vectors for gene therapy | |
CY1106216T1 (el) | 5´ ESTs ΓΙΑ ΜΗ ΙΣΤΟ-ΕΙΔΙΚΕΣ ΕΚΚΡΙΤΙΚΕΣ ΠΡΩΤΕΪΝΕΣ | |
NL187785B (nl) | Chirurgische kraminrichting. | |
ZA942778B (en) | Recombinant viruses, and their preparation and use in gene therapy. | |
DK586685A (da) | Antitumor-aktivt stof, fremgangsmaade til dets fremstilling, laegemiddel indeholdende stoffet, gen kodende for stoffet, vektor indeholdende genet samt rekombinant mikroorganisme | |
FI973309A0 (fi) | Menetelmä yhdistelmä-DNA-adenovirusgenomin valmistamiseksi | |
ATE188507T1 (de) | Polyphenol oxidase gene | |
NO862975D0 (no) | Kvaternaere oksalkylerte polykondensater, fremgangsmaate til deres fremstilling, og deres anvendelse. | |
NO840952L (no) | Fremgangsmaate til fremstilling av et humant interferon-gamma-polypeptid, rekombinant plasmid omfattende et dna-fragment som koder for peptidet, og mikroorganisme transfermert med plasmidet | |
DK47887A (da) | Vektor til transfektion af en celle til opnaaelse af et hoejt genekspressionsniveau | |
EP0213898A3 (en) | A host-vector system | |
FI964784A (fi) | Yhdistelmä-DNA-viruksia, valmistus ja käyttö geeniterapiassa | |
FI884556A (fi) | Rekombinantplasmid-dna ppr-ifn 1-13, som kodas foer syntes av maenniskans fibroblast- 1-interferon, foerfarande foer framstaellning daerav och e.coli innehaollande detta. | |
HUP9901346A2 (hu) | Deltap62 polipeptid és variánsai, ezeket kódoló nukleinsav-szekvenciák és felhasználásuk | |
DE59914061D1 (de) | Das gen prv-1 und dessen verwendung | |
DE69938427D1 (de) | Tes gen und dessen verwendung | |
SE8602945L (sv) | Kopplingsmedel for termoplaster och oorganiska armeringsmedel | |
COOK | BLOCKLEYS' CLAY PAVIORS- THE TOTAL CONCEPT. | |
IT8521689V0 (it) | Calandra per l'accoppiamento e la sagomatura di elementi lastriformi, particolarmente studiata per la realizzazione di cinture. | |
IT8419660A0 (it) | Acido 2-(2,4-dimetil-6-piridinil)ammino nicotino e procedimento per la preparazione. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1115290 Country of ref document: EP |